1st EuroFlow Winter Course on MRD - Prague
Minimal measurable disease (MRD) has become of utmost importance for therapy montoring in hematological diseases, including B- and T-lymphoblastic Leukemia (B-ALL, T-ALL), Multiple Myeloma (MM) and Chronic Lymphatic Leukemia (CLL). The EuroFlow methods and tubes for MRD analysis are of high sensitivity and specificity and - for MM-MRD - considered the leading standard.
The EuroFlow Winter Course on MRD is designed as hands-on, case-based intensive training for already experienced clinical cytometrists, introducing them to to EuroFlow procedures, analysis of the EuroFlow panels and use of its associated databases in InfinicytTM.
The Winter School is open to 40 participants maximum. The theory behind each topic will be first explained by an EuroFlow expert on the subject, followed by a live demonstration of case-analysis with discussion of strategy and pitfalls. After that participants will be given case files to solve individually or in small groups, assisted by tutors. In case students are not interested in a specific topic, a separate classroom with faculty is available for assisted self-training on case files of interest. All tutors are experienced lecturers from the EuroFlow Consortium.
Preliminary program
The course is given at the historical seat of Charles University in the historical heart of Prague (the Carolinum).
Join us for a guided tour through historical Carolinum on Wednesday, and we look forward to network with students and faculty at the Social Event on Thursday evening!
Who is this course for?
The EuroFlow Winter Course is designed for advanced cytometrists with over 3 years of clinical flow experience, analyzing data and preparing reports. To fully benefit from the course, we recommend at least basic knowledge of Infinicyt software. If you do not have a direct access to it, video tutorials and demo version may be available online, check BD Biosciences/Cytognos websites. It is not an obstacle if you are not interested in all of the topics, you may alternatively join the other track (acute leukemia vs mature malignancies). Nevertheless, at least two topics should be in your focus.
Are you still in doubt if this course is right for you, please send an email to Campus@euroFlow.org and we will set you in contact with one of our lecturers. The course will be given In English.
Location
The 1st EuroFlow Winter Course will take place in the capital of the Czech Republic, Prague. The venue is inside the historical Carolinum complex, the seat of the Charles University since 1348, located in the Old Town.
Address
Ovocný trh 541/3, 11000 Prague 1 - Old Town
(closest metro station is Mustek)
Prague’s main airport is Václav Havel Airport (formerly known as Prague Ruzyne Airport), PRG. From this airport to the city center, you have several transport options to reach the town center.
Transportation
Václav Havel Airport Prague handles flights of most European carriers and also some overseas flights. It is located 40 minutes by car from the center of Prague. There is a good connection between the airport and city center by public transport (bus + metro) and taxis. Credit cards are accepted.
Hotels
The course takes place in the heart of the city of Prague, just a stone’s throw away from the famous Prague Astronomical Clock and the Church of Our Lady before Týn. In this area you can find numerous accommodations in walking distance of the University.
Costs
The non-discounted price for the two-and a half-day course are € 600,-. Payment needs to be made upon registration.
NB: Employees of academic laboratories (University or public hospitals) get a 50% discount. Please tick the box on registration!
This includes:
- Materials
- Lunches and Breaks
- Networking event
- Participants are also invited to attend the yearly EuroFlow EQA meeting which will take place on Friday February 21st from 13.00 to 17.30
You need to bring your own laptop computer
Registration
Registration will be open soon on this website! Keep an eye on this page. Be sure to be in time, only 40 places are available! After that we will operate a waiting list.
